Brief: Galderma Announces Triple Approval Of Restylane Syringe

Galderma AG

25/02/2026 06:04

Feb 25 (Reuters) - GALDERMA GROUP LTD GALD.S:

ANNOUNCES TRIPLE APPROVAL OF NEW STATE-OF-THE-ART RESTYLANE® SYRINGE IN THE EU, THE U.S., AND CANADA, REAFFIRMING THE COMPANY’S POSITION AT THE FOREFRONT OF INJECTABLE AESTHETICS

Source text: ID:nBw25DLyPa

Further company coverage: GALD.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))